Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Buzz on the Bullboards: In the COVID Fallout, New Players Emerge

Back in early March 2020, the COVID-19 pandemic was still not much of a concern for the markets. While investors were keeping an eye on it, compared to other geopolitical factors at the time, it was mostly an afterthought of little consequence. Fast-forward a year...
Stockhouse Editorial | March 3, 2021 |

A Unique Solution to Meet Lithium’s Supply Gap

(Chart via Benchmark Mineral Intelligence. Click to enlarge.) A lithium supply gap? There is demand growth, but it is stifled by limited investments in mines and converters. A key theme for mining investors in 2021 revolves around the acceleration in demand fo...
Stockhouse Editorial | January 29, 2021 |

MEI Pharma Shares Rise 50% on $682.5M Partnership with Japanese Company to Treat B-cell Malignancies

Shares of MEI Pharma traded higher after the company announced that it has entered into development and global licensing agreement with Kyowa Kirin for its oral selective PI3Kd inhibitor (ME-401) used for treating B-cell malignancies. Late-stage pharmaceutic...
Streetwise Reports | April 15, 2020 |

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Sangamo Therapeutics and partner Pfizer reported positive results for phase 1/2 Alta study for hemophilia A at the International Society on Thrombosis and Hemostasis Congress in Melbourne, Australia. Sangamo Therapeutics Inc. (SGMO:NASDAQ) shares are up...
Streetwise Reports | July 9, 2019 |

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

In the fight against the spread of the Corona Pandemic, a great deal of commitment is required from companies. This situation also offers the opportunity to rethink and change existing work processes and procedures. Product ranges are being expanded and new possibilities and a...
Mario Hose | September 18, 2020 |

Increased Cannabis Interest Paves Way for Cannabinoid Production

As the cannabis market has started to recover amidst the COVID-19 pandemic, investors are looking at where the market can grow. One leading candidate is cannabinoid production. THC, CBD, and other specific cannabinoids can be useful for a variety of treatments, includ...
Omri Wallach | June 9, 2020 |

Morning Market Outlook for Nov. 27, 2023

Stephen Whiteside of TheUpTrend.com analyzes a variety of data in the Morning Market Outlook for Monday to see if recent bullish trends continue. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with daily updates on TSX, S&P 500, ...
TheUpTrend | November 27, 2023 |

In Conversation with Willow Biosciences – Perspectives from an Analyst & CEO

Valuation, investor perception and Willow’s ( TSX: WLLW ) market opportunity as it closes in on the production of commercial quantities of pharma grade CBD and rare cannabinoids were amongst a variety of topics covered in a recent conversation between Gr...
Featured Submission | July 14, 2020 |

Guyana Goldstrike discovers mineralized outcrops along 1,100m trend

Guyana Goldstrike (TSX-V:GYA) has come across very prospective new ground at its Marudi Gold Project in Guyana, as it identifies targets for its 2019 drill program in the small country wedged between Venezuela, Brazil and Suriname. The junior gold explorer put out a...
Richard (Rick) Mills | May 16, 2019 |

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |
1 2 3 4 5 6 7 8 9 10 ...